Page last updated: 2024-09-03

pramipexole and Lassitude

pramipexole has been researched along with Lassitude in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fu Wang, Y; Lin Wang, S; Liu, GJ; Wu, L; Xu, LL; Ying Chang, L1
Nodel', MR1
Hashimoto, S; Hatano, T; Hattori, N; Hirata, K; Kamei, S; Matsumura, M; Miyamoto, M; Miyamoto, T; Morita, A; Nogawa, S; Okuma, Y; Takahashi, K; Utsumi, H; Watanabe, Y; Yamamoto, T; Yoshii, F1
Tarrants, ML; Zagmutt, FJ1
Holman, AJ; Myers, RR1

Reviews

2 review(s) available for pramipexole and Lassitude

ArticleYear
Efficacy of Pramipexole for the Treatment of Primary Restless Leg Syndrome: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
    Clinical therapeutics, 2016, Jan-01, Volume: 38, Issue:1

    Topics: Benzothiazoles; Dopamine Agonists; Fatigue; Humans; Pramipexole; Quality of Life; Randomized Controlled Trials as Topic; Restless Legs Syndrome; Severity of Illness Index; Sleep; Treatment Outcome

2016
Indirect comparisons of adverse events and dropout rates in early Parkinson's disease trials of pramipexole, ropinirole, and rasagiline.
    The International journal of neuroscience, 2012, Volume: 122, Issue:7

    Topics: Antiparkinson Agents; Benzothiazoles; Cognition Disorders; Cross-Sectional Studies; Databases, Bibliographic; Fatigue; Female; Gastrointestinal Diseases; Humans; Indans; Indoles; Logistic Models; Male; Parkinson Disease; Patient Dropouts; Pramipexole; Sleep Wake Disorders; Treatment Outcome

2012

Trials

2 trial(s) available for pramipexole and Lassitude

ArticleYear
Pramipexole reduces the prevalence of fatigue in patients with Parkinson's disease.
    Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:19

    Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Cross-Sectional Studies; Fatigue; Female; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole

2011
A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications.
    Arthritis and rheumatism, 2005, Volume: 52, Issue:8

    Topics: Adult; Analgesics, Opioid; Benzothiazoles; Disabled Persons; Dopamine Agonists; Double-Blind Method; Drug Therapy, Combination; Fatigue; Female; Fibromyalgia; Humans; Male; Middle Aged; Pain; Pramipexole; Thiazoles; Treatment Outcome

2005

Other Studies

1 other study(ies) available for pramipexole and Lassitude

ArticleYear
[Fatigability in Parkinson's disease].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2009, Volume: 109, Issue:9

    Topics: Activities of Daily Living; Antiparkinson Agents; Benzothiazoles; Fatigue; Humans; Middle Aged; Parkinson Disease; Pramipexole; Prognosis; Receptors, Dopamine D1; Surveys and Questionnaires

2009